Organizations Filed Purposes:
TO IMPROVE THE QUALITY OF MEDICATION MANAGEMENT AND USE ACROSS HEALTHCARE SETTINGS WITH THE GOAL OF IMPROVING PATIENTS' HEALTH THROUGH A COLLABORATIVE PROCESS TO DEVELOP AND IMPLEMENT PERFORMANCE MEASURES AND RECOGNIZE EXAMPLES OF EXCEPTIONAL PHARMACY QUALITY.
THE ORGANIZATION'S PROGRAMS ARE THE FOLLOWING: 1) MEASURE DEVELOPMENT AND TESTING - PQA USES ITS RESOURCES TO CREATE AND DEVELOP PERFORMANCE MEASURES OF APPROPRIATE MEDICATION USE THAT CAN BE USED IN VARIOUS SETTINGS. THESE MEASURES RELATE TO PATIENTS' ADHERENCE TO MEDICATIONS USED TO TREAT CHRONIC DISEASES, PATIENTS' USE OF APPROPRIATE MEDICATIONS TO AVOID RISK TO THE ELDERLY POPULATION, AND ALSO MEASURES TO ADDRESS APPROPRIATE USE OF SEVERAL SPECIFIC THERAPEUTIC CATEGORIES OF MEDICATIONS, THAT TEND TO BE OVERUSED; 2) PQA ALSO SUPPORTS PROJECTS THAT UTILIZE PERFORMANCE MEASURES AND CREATE INTERVENTIONS THAT CAN BE USED AT THE POINT OF CARE TO DRIVE IMPROVEMENTS IN QUALITY AND PATIENT CARE.
MEASURE CONCEPTS FOR NEW DEVELOPMENT ARE IDENTIFIED THROUGH ENVIRONMENTAL SCANS AND THEN PRIORITIZED BY PQA STAFF WITH INPUT FROM MEMBERS. CONCEPTS SELECTED FOR DEVELOPMENT ALIGN WITH NATIONAL PRIORITIES, REPRESENT AREAS WHERE THERE ARE CLINICAL AND MEASUREMENT GAPS, AND HAVE THE GREATEST POTENTIAL FOR ADOPTION IN EXISTING MEASURE SETS AND PERFORMANCE SYSTEMS.
AS A QUALITY MEASURE RESEARCHER, PQA IS ENGAGED IN A WIDE VARIETY OF PROJECTS AND INITIATIVES POSITIONED ON INTERDISCIPLINARY COLLABORATION WITH MEMEBER ORGNIZATIONS AND QUALITY STAKEHOLDERS. AS A HEALTHCARE QUALITY EDUCATOR, PQA OFFERS A WIDE RANGE OF LEARNING AND EDUCATION OPPORTUNITIES TO MEMBERS. THE GOAL OF OUR MEMER EDUCATION PROGRAM IS TO PROMOTE THE USE AND IMPACT OF PQA MEASURES AND OTHER HEALTHCARE QUALITY TOPICS. MEMBERS CAN ACCESS TEH FULL ARCHIVES OF ALL EDUCATIONAL MATERIALS ON THE MEMBER PORTAL.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
Name | Title | Hours Per Week | Total Salary |
Laura Cranston Rph | CHIEF EXECUTIVE OFFICER | 40 | $588,656 |
Jacqueline A Green | CHIEF OPERATING OFFICER | 40 | $271,554 |
Norris Turner | VICE PRESIDENT | 40 | $265,870 |
Lisa Hines | VICE PRESIDENT | 40 | $184,940 |
Lynn Pezzullo | SENIOR DIRECTOR | 40 | $175,748 |
Matt Pickering | SENIOR DIRECTOR | 40 | $157,450 |
Susan A Cantrell Rph Cae | DIRECTOR | 1 | $0 |
Troy Trygstad | DIRECTOR | 1 | $0 |
Jason Spangler Md Mph Facpm | DIRECTOR | 1 | $0 |
Cynthia Pigg Bspharm Mha Famcp | DIRECTOR | 1 | $0 |
Vic Perini Rph | DIRECTOR | 1 | $0 |
Bhavesh Modi Rph | DIRECTOR | 1 | $0 |
Jeffrey Kelman Md | DIRECTOR | 1 | $0 |
Sharon Jhawar Pharm D Mba Cgp | DIRECTOR | 1 | $0 |
Ronna B Hauser Pharmd | DIRECTOR | 1 | $0 |
Rick Gates | DIRECTOR | 1 | $0 |
Mike Duteau | DIRECTOR | 1 | $0 |
Lou Dallago | DIRECTOR | 1 | $0 |
Christie Boutte Pharmd Prh | DIRECTOR | 1 | $0 |
Alan Balch Phd | DIRECTOR | 1 | $0 |
Mike Anderson Pharmd | DIRECTOR | 1 | $0 |
Vikki Ahern | DIRECTOR | 1 | $0 |
Jerry Penso Md Mba | SECRETARY | 1 | $0 |
Anne Burns Rph | TREASURER | 1 | $0 |
Jamie Chan Pharmd | VICE CHAIR | 1 | $0 |
Mary Ann Kliethermes Bs Pharmd | IMMEDIATE PAST CHAIR | 1 | $0 |
David Medvedeff Pharmd Mba | CHAIR | 1 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202023089349301982_public.xml